fred module from oedocking software v. 3.2.0.2 (OpenEye Scientific Software Inc)
90
Structured Review
OpenEye Scientific Software Inc
fred module from oedocking software v. 3.2.0.2
Fred Module From Oedocking Software V. 3.2.0.2, supplied by OpenEye Scientific Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fred+module+from+oedocking+software+v%2E+3%2E2%2E0%2E2/fred+module+from+oedocking+software+v++3+2+0+2/10__1016_slash_j__bmcl__2017__07__061-49-32-36
Average 90 stars, based on 1 article reviews
Fred Module From Oedocking Software V. 3.2.0.2, supplied by OpenEye Scientific Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fred+module+from+oedocking+software+v%2E+3%2E2%2E0%2E2/fred+module+from+oedocking+software+v++3+2+0+2/10__1016_slash_j__bmcl__2017__07__061-49-32-36
Average 90 stars, based on 1 article reviews
fred module from oedocking software v. 3.2.0.2 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: Novel anti-prostate cancer scaffold identified by the combination of in silico and cell-based assays targeting the PI3K-AKT-mTOR pathway Article Snippet: Phenotypic assays were performed in prostate cancer cell lines to describe the biological activity of PI3K-AKT-mTOR pathway inhibitors retrieved from the virtual screening initiative.. These novel chemicals share in common the aminopyridine scaffold, hitting PC-3 cells in macromolar range, with selectivity index over fibroblast cell lines.. Moreover, a preliminary study of the mode of action by flow cytometry assay pointed out that these compounds had a rapamycin-like response for the PI3K-AKT-mTOR pathway modulation. Binding Assay:Article Title: Novel anti-prostate cancer scaffold identified by the combination of in silico and cell-based assays targeting the PI3K-AKT-mTOR pathway Article Snippet: Phenotypic assays were performed in prostate cancer cell lines to describe the biological activity of PI3K-AKT-mTOR pathway inhibitors retrieved from the virtual screening initiative.. These novel chemicals share in common the aminopyridine scaffold, hitting PC-3 cells in macromolar range, with selectivity index over fibroblast cell lines.. Moreover, a preliminary study of the mode of action by flow cytometry assay pointed out that these compounds had a rapamycin-like response for the PI3K-AKT-mTOR pathway modulation. |